<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38605121</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Apr</Month><Day>11</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Next-generation sequencing of host genetics risk factors associated with COVID-19 severity and long-COVID in Colombian population.</ArticleTitle><Pagination><StartPage>8497</StartPage><MedlinePgn>8497</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">8497</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-57982-3</ELocationID><Abstract><AbstractText>Coronavirus disease 2019 (COVID-19) was considered a major public health burden worldwide. Multiple studies have shown that susceptibility to severe infections and the development of long-term symptoms is significantly influenced by viral and host factors. These findings have highlighted the potential of host genetic markers to identify high-risk individuals and develop target interventions to reduce morbimortality. Despite its importance, genetic host factors remain largely understudied in Latin-American populations. Using a case-control design and a custom next-generation sequencing (NGS) panel encompassing 81 genetic variants and 74 genes previously associated with COVID-19 severity and long-COVID, we analyzed 56 individuals with asymptomatic or mild COVID-19 and 56 severe and critical cases. In agreement with previous studies, our results support the association between several clinical variables, including male sex, obesity and common symptoms like cough and dyspnea, and severe COVID-19. Remarkably, thirteen genetic variants showed an association with COVID-19 severity. Among these variants, rs11385942 (p&#x2009;&lt;&#x2009;0.01; OR&#x2009;=&#x2009;10.88; 95% CI&#x2009;=&#x2009;1.36-86.51) located in the LZTFL1 gene, and rs35775079 (p&#x2009;=&#x2009;0.02; OR&#x2009;=&#x2009;8.53; 95% CI&#x2009;=&#x2009;1.05-69.45) located in CCR3 showed the strongest associations. Various respiratory and systemic symptoms, along with the rs8178521 variant (p&#x2009;&lt;&#x2009;0.01; OR&#x2009;=&#x2009;2.51; 95% CI&#x2009;=&#x2009;1.27-4.94) in the IL10RB gene, were significantly associated with the presence of long-COVID. The results of the predictive model comparison showed that the mixed model, which incorporates genetic and non-genetic variables, outperforms clinical and genetic models. To our knowledge, this is the first study in Colombia and Latin-America proposing a predictive model for COVID-19 severity and long-COVID based on genomic analysis. Our study highlights the usefulness of genomic approaches to studying host genetic risk factors in specific populations. The methodology used allowed us to validate several genetic variants previously associated with COVID-19 severity and long-COVID. Finally, the integrated model illustrates the importance of considering genetic factors in precision medicine of infectious diseases.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Angulo-Aguado</LastName><ForeName>Mariana</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Medicine and Health Sciences, Center for Research in Genetics and Genomics (CIGGUR), Institute of Translational Medicine (IMT), Universidad Del Rosario, Bogot&#xe1;, D.C, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Carrillo-Martinez</LastName><ForeName>Juan Camilo</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>School of Medicine and Health Sciences, Center for Research in Genetics and Genomics (CIGGUR), Institute of Translational Medicine (IMT), Universidad Del Rosario, Bogot&#xe1;, D.C, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Contreras-Bravo</LastName><ForeName>Nora Constanza</ForeName><Initials>NC</Initials><AffiliationInfo><Affiliation>School of Medicine and Health Sciences, Center for Research in Genetics and Genomics (CIGGUR), Institute of Translational Medicine (IMT), Universidad Del Rosario, Bogot&#xe1;, D.C, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morel</LastName><ForeName>Adrien</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Medicine and Health Sciences, Center for Research in Genetics and Genomics (CIGGUR), Institute of Translational Medicine (IMT), Universidad Del Rosario, Bogot&#xe1;, D.C, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parra-Abaunza</LastName><ForeName>Katherine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Hospital Universitario Mayor - M&#xe9;deri - Universidad del Rosario, Bogot&#xe1;, D.C, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Usaqu&#xe9;n</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Populations Genetics and Identification Group, Institute of Genetics, Universidad Nacional de Colombia, Bogot&#xe1;, D.C, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fonseca-Mendoza</LastName><ForeName>Dora Janeth</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>School of Medicine and Health Sciences, Center for Research in Genetics and Genomics (CIGGUR), Institute of Translational Medicine (IMT), Universidad Del Rosario, Bogot&#xe1;, D.C, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ortega-Recalde</LastName><ForeName>Oscar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>School of Medicine and Health Sciences, Center for Research in Genetics and Genomics (CIGGUR), Institute of Translational Medicine (IMT), Universidad Del Rosario, Bogot&#xe1;, D.C, Colombia. oortegar@unal.edu.co.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Morfolog&#xed;a, Facultad de Medicina e Instituto de Gen&#xe9;tica, Universidad Nacional de Colombia, Bogot&#xe1;, D.C, Colombia. oortegar@unal.edu.co.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>QAN-BG277</GrantID><Agency>Hospital Universitario Mayor - M&#xe9;deri</Agency><Country/></Grant><Grant><GrantID>QAN-BG277</GrantID><Agency>Hospital Universitario Mayor - M&#xe9;deri</Agency><Country/></Grant><Grant><GrantID>ABN062</GrantID><Agency>Universidad del Rosario</Agency><Country/></Grant><Grant><GrantID>ABN062</GrantID><Agency>Universidad del Rosario</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003105" MajorTopicYN="N" Type="Geographic">Colombia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059014" MajorTopicYN="N">High-Throughput Nucleotide Sequencing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Next-generation sequencing</Keyword><Keyword MajorTopicYN="N">Personalized medicine</Keyword><Keyword MajorTopicYN="N">Predictive model</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>12</Day><Hour>0</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>11</Day><Hour>23</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38605121</ArticleId><ArticleId IdType="pmc">PMC11009356</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-57982-3</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-57982-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard [Internet]. [cited 2023 Sep 3]. Available from: https://covid19.who.int</Citation></Reference><Reference><Citation>Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet. Infect. Dis. 2020;20:669&#x2013;677. doi: 10.1016/S1473-3099(20)30243-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30243-7</ArticleId><ArticleId IdType="pmc">PMC7158570</ArticleId><ArticleId IdType="pubmed">32240634</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang F, Deng L, Zhang L, Cai Y, Cheung CW, Xia Z. Review of the clinical characteristics of coronavirus disease 2019 (COVID-19) J. Gen. Intern. Med. 2020;35:1545&#x2013;1549. doi: 10.1007/s11606-020-05762-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-020-05762-w</ArticleId><ArticleId IdType="pmc">PMC7088708</ArticleId><ArticleId IdType="pubmed">32133578</ArticleId></ArticleIdList></Reference><Reference><Citation>Dao TL, Hoang VT, Colson P, Lagier JC, Million M, Raoult D, et al. SARS-CoV-2 infectivity and severity of COVID-19 according to SARS-CoV-2 variants: Current evidence. JCM. 2021;10:2635. doi: 10.3390/jcm10122635.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10122635</ArticleId><ArticleId IdType="pmc">PMC8232800</ArticleId><ArticleId IdType="pubmed">34203844</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff D, Nee S, Hickey NS, Marschollek M. Risk factors for Covid-19 severity and fatality: A structured literature review. Infection. 2021;49:15&#x2013;28. doi: 10.1007/s15010-020-01509-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-020-01509-1</ArticleId><ArticleId IdType="pmc">PMC7453858</ArticleId><ArticleId IdType="pubmed">32860214</ArticleId></ArticleIdList></Reference><Reference><Citation>The COVID-19 Host Genetics Initiative. The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic. Eur J Hum Genet. 2020;28:715&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7220587</ArticleId><ArticleId IdType="pubmed">32404885</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikitimur H, Borku Uysal B, Cengiz M, Ikitimur B, Uysal H, Ozcan E, et al. Determining host factors contributing to disease severity in a family cluster of 29 hospitalized SARS-CoV-2 patients: Could genetic factors be relevant in the clinical course of COVID-19? J. Med. Virol. 2021;93:357&#x2013;365. doi: 10.1002/jmv.26106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26106</ArticleId><ArticleId IdType="pmc">PMC7300487</ArticleId><ArticleId IdType="pubmed">32492209</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. Healthcare Workers [Internet]. Centers for Disease Control and Prevention. 2020 [cited 2022 Dec 20]. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/clinical-considerations-course.html</Citation></Reference><Reference><Citation>CDC. Coronavirus Disease 2019 (COVID-19) [Internet]. Centers for Disease Control and Prevention. 2020 [cited 2022 Dec 20]. https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-classifications.html</Citation></Reference><Reference><Citation>Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: A systematic review and meta-analysis. Int. J. Infect. Dis. 2020;94:91&#x2013;95. doi: 10.1016/j.ijid.2020.03.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.03.017</ArticleId><ArticleId IdType="pmc">PMC7194638</ArticleId><ArticleId IdType="pubmed">32173574</ArticleId></ArticleIdList></Reference><Reference><Citation>Ovsyannikova IG, Haralambieva IH, Crooke SN, Poland GA, Kennedy RB. The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity. Immunol. Rev. 2020;296:205&#x2013;219. doi: 10.1111/imr.12897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12897</ArticleId><ArticleId IdType="pmc">PMC7404857</ArticleId><ArticleId IdType="pubmed">32658335</ArticleId></ArticleIdList></Reference><Reference><Citation>Velavan TP, Pallerla SR, R&#xfc;ter J, Augustin Y, Kremsner PG, Krishna S, et al. Host genetic factors determining COVID-19 susceptibility and severity. eBioMedicine. 2021;72:103629. doi: 10.1016/j.ebiom.2021.103629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103629</ArticleId><ArticleId IdType="pmc">PMC8512556</ArticleId><ArticleId IdType="pubmed">34655949</ArticleId></ArticleIdList></Reference><Reference><Citation>Mousa M, Vurivi H, Kannout H, Uddin M, Alkaabi N, Mahboub B, et al. Genome-wide association study of hospitalized COVID-19 patients in the United Arab Emirates. eBioMedicine. 2021;74:103695. doi: 10.1016/j.ebiom.2021.103695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103695</ArticleId><ArticleId IdType="pmc">PMC8587122</ArticleId><ArticleId IdType="pubmed">34775353</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, Huang S, Gao R, Zhou Y, Lai C, Li Z, et al. Initial whole-genome sequencing and analysis of the host genetic contribution to COVID-19 severity and susceptibility. Cell Discov. 2020;6:83. doi: 10.1038/s41421-020-00231-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-020-00231-4</ArticleId><ArticleId IdType="pmc">PMC7653987</ArticleId><ArticleId IdType="pubmed">33298875</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Host Genetics Initiative [Internet]. [cited 2023 Sep 3]. https://www.covid19hg.org/partners/</Citation></Reference><Reference><Citation>Butler-Laporte, G,, Povysil, G., Kosmicki, J.A., Cirulli, E.T., Drivas, T., Furini, S., et al. Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the host genetics initiative. Infect. Dis. Except HIV/AIDS; 2022. 10.1101/2022.03.28.22273040</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9632827</ArticleId><ArticleId IdType="pubmed">36327219</ArticleId></ArticleIdList></Reference><Reference><Citation>Marik PE, Iglesias J, Varon J, Kory P. A scoping review of the pathophysiology of COVID-19. Int. J. Immunopathol. Pharmacol. 2021;35:205873842110480. doi: 10.1177/20587384211048026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20587384211048026</ArticleId><ArticleId IdType="pmc">PMC8477699</ArticleId><ArticleId IdType="pubmed">34569339</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: A review. Clin. Immunol. 2020;215:108427. doi: 10.1016/j.clim.2020.108427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108427</ArticleId><ArticleId IdType="pmc">PMC7169933</ArticleId><ArticleId IdType="pubmed">32325252</ArticleId></ArticleIdList></Reference><Reference><Citation>Raza RZ, Abbasi SW. An evolutionary insight into the heterogeneous severity pattern of the SARS-CoV-2 infection. Front. Genet. 2022;13:859508. doi: 10.3389/fgene.2022.859508.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2022.859508</ArticleId><ArticleId IdType="pmc">PMC8981084</ArticleId><ArticleId IdType="pubmed">35391792</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerner G, Quintana-Murci L. The genetic and evolutionary determinants of COVID-19 susceptibility. Eur. J. Hum. Genet. 2022;30:915&#x2013;921. doi: 10.1038/s41431-022-01141-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41431-022-01141-7</ArticleId><ArticleId IdType="pmc">PMC9244541</ArticleId><ArticleId IdType="pubmed">35760904</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet T. COVID-19 in Latin America&#x2014;emergency and opportunity. The Lancet. 2021;398:93. doi: 10.1016/S0140-6736(21)01551-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01551-8</ArticleId><ArticleId IdType="pmc">PMC8266269</ArticleId><ArticleId IdType="pubmed">34246349</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronavirus Colombia [Internet]. [cited 2024 Feb 24]. Available from: https://www.ins.gov.co/Noticias/Paginas/Coronavirus.aspx</Citation></Reference><Reference><Citation>Prada SI, Garcia-Garcia MP, Guzman J. COVID-19 response in Colombia: Hits and misses. Health Policy Technol.. 2022;11:100621. doi: 10.1016/j.hlpt.2022.100621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlpt.2022.100621</ArticleId><ArticleId IdType="pmc">PMC8940255</ArticleId><ArticleId IdType="pubmed">35340774</ArticleId></ArticleIdList></Reference><Reference><Citation>Balboa-Castillo T, Andrade-Mayorga O, Marzuca-Nassr GN, Morales Illanes G, Ortiz M, Schiferlli I, et al. Pre-existing conditions in Latin America and factors associated with adverse outcomes of COVID-19: A review. Medwave. 2021;21:e8180&#x2013;8180. doi: 10.5867/medwave.2021.04.8180.</Citation><ArticleIdList><ArticleId IdType="doi">10.5867/medwave.2021.04.8180</ArticleId><ArticleId IdType="pubmed">34037583</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xf6;nfeld D, Arias S, Bossio JC, Fern&#xe1;ndez H, Gozal D, P&#xe9;rez-Chada D. Clinical presentation and outcomes of the first patients with COVID-19 in Argentina: Results of 207079 cases from a national database. Di Gennaro F, editor. PLoS ONE. 2021;16:e0246793.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7877635</ArticleId><ArticleId IdType="pubmed">33571300</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuniga-Moya JC, Norwood DA, Romero Reyes LE, Barrueto Saavedra E, Diaz R, Fajardo WC, et al. Epidemiology, outcomes, and associated factors of coronavirus disease 2019 (COVID-19) reverse transcriptase polymerase chain reaction-confirmed cases in the san Pedro Sula metropolitan area Honduras. Clin. Infect. Dis.. 2021;72:e476&#x2013;e483. doi: 10.1093/cid/ciaa1188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1188</ArticleId><ArticleId IdType="pmc">PMC7454370</ArticleId><ArticleId IdType="pubmed">32803236</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd1;amendys-Silva SA, Alvarado-&#xc1;vila PE, Dom&#xed;nguez-Cherit G, Rivero-Sigarroa E, S&#xe1;nchez-Hurtado LA, Guti&#xe9;rrez-Villase&#xf1;or A, et al. Outcomes of patients with COVID-19 in the intensive care unit in Mexico: A multicenter observational study. Heart Lung. 2021;50:28&#x2013;32. doi: 10.1016/j.hrtlng.2020.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrtlng.2020.10.013</ArticleId><ArticleId IdType="pmc">PMC7577687</ArticleId><ArticleId IdType="pubmed">33138974</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwendi C, Huescas CGY, Chakraborty C, Mohan S. COVID-19 health analysis and prediction using machine learning algorithms for Mexico and Brazil patients. Journal of Experimental &amp; Theoretical Artificial Intelligence. 2022;1&#x2013;21.</Citation></Reference><Reference><Citation>Molina-Mora JA, Gonz&#xe1;lez A, Jim&#xe9;nez-Morgan S, Cordero-Laurent E, Brenes H, Soto-Garita C, et al. Clinical profiles at the time of diagnosis of SARS-CoV-2 infection in costa rica during the pre-vaccination period using a machine learning approach. Phenomics. 2022;2:312&#x2013;322. doi: 10.1007/s43657-022-00058-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s43657-022-00058-x</ArticleId><ArticleId IdType="pmc">PMC9173838</ArticleId><ArticleId IdType="pubmed">35692458</ArticleId></ArticleIdList></Reference><Reference><Citation>Nhung VP, Ton ND, Ngoc TTB, Thuong MTH, Hai NTT, Oanh KTP, et al. Host genetic risk factors associated with COVID-19 susceptibility and severity in Vietnamese. Genes. 2022;13:1884. doi: 10.3390/genes13101884.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes13101884</ArticleId><ArticleId IdType="pmc">PMC9601961</ArticleId><ArticleId IdType="pubmed">36292769</ArticleId></ArticleIdList></Reference><Reference><Citation>Shcherbak SG, Changalidi AI, Barbitoff YA, Anisenkova AYu, Mosenko SV, Asaulenko ZP, et al. Identification of Genetic Risk Factors of Severe COVID-19 Using Extensive Phenotypic Data: A Proof-of-Concept Study in a Cohort of Russian Patients. Genes. 2022;13:534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8949130</ArticleId><ArticleId IdType="pubmed">35328087</ArticleId></ArticleIdList></Reference><Reference><Citation>Asteris PG, Gavriilaki E, Touloumenidou T, Koravou E, Koutra M, Papayanni PG, et al. Genetic prediction of ICU hospitalization and mortality in COVID-19 patients using artificial neural networks. J. Cell. Mol. Med. 2022;26:1445&#x2013;1455. doi: 10.1111/jcmm.17098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.17098</ArticleId><ArticleId IdType="pmc">PMC8899198</ArticleId><ArticleId IdType="pubmed">35064759</ArticleId></ArticleIdList></Reference><Reference><Citation>Saavedra Trujillo CH. Consenso colombiano de atenci&#xf3;n, diagn&#xf3;stico y manejo de la infecci&#xf3;n por SARS-COV-2/COVID 19 en establecimientos de atenci&#xf3;n de la salud. Recomendaciones basadas en consenso de expertos e informadas en la evidencia. Infect. 2020;24:1. doi: 10.22354/in.v24i3.851.</Citation><ArticleIdList><ArticleId IdType="doi">10.22354/in.v24i3.851</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibitoye OS, Olasunkanmi YA, Olowolafe TA, Olabode AT, Salawu MM, Afolabi RF. Predictors and time to recovery from COVID-19 among patients attended to at treatment centers in Ekiti State, South West Nigeria. Pan Afr Med J. 2022;42:18. doi: 10.11604/pamj.2022.42.18.33791.</Citation><ArticleIdList><ArticleId IdType="doi">10.11604/pamj.2022.42.18.33791</ArticleId><ArticleId IdType="pmc">PMC9228920</ArticleId><ArticleId IdType="pubmed">35812253</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabavi, N. Long covid: How to define it and how to manage it. BMJ. 2020;m3489.</Citation><ArticleIdList><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Pijls BG, Jolani S, Atherley A, Derckx RT, Dijkstra JIR, Franssen GHL, et al. Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies. BMJ Open. 2021;11:e044640. doi: 10.1136/bmjopen-2020-044640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-044640</ArticleId><ArticleId IdType="pmc">PMC7802392</ArticleId><ArticleId IdType="pubmed">33431495</ArticleId></ArticleIdList></Reference><Reference><Citation>Angulo-Aguado M, Corredor-Orlandelli D, Carrillo-Mart&#xed;nez JC, Gonzalez-Cornejo M, Pineda-Mateus E, Rojas C, et al. Association between the LZTFL1 rs11385942 polymorphism and COVID-19 severity in colombian population. Front. Med. 2022;9:910098. doi: 10.3389/fmed.2022.910098.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.910098</ArticleId><ArticleId IdType="pmc">PMC9251207</ArticleId><ArticleId IdType="pubmed">35795626</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan KM, Dean A, Soe MM. On Academics: OpenEpi: A web-based epidemiologic and statistical calculator for public health. Public Health Rep. 2009;124:471&#x2013;474. doi: 10.1177/003335490912400320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/003335490912400320</ArticleId><ArticleId IdType="pmc">PMC2663701</ArticleId><ArticleId IdType="pubmed">19445426</ArticleId></ArticleIdList></Reference><Reference><Citation>Suh S, Lee S, Gym H, Yoon S, Park S, Cha J, et al. A systematic review on papers that study on Single Nucleotide Polymorphism that affects coronavirus 2019 severity. BMC Infect. Dis. 2022;22:47. doi: 10.1186/s12879-022-07034-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07034-w</ArticleId><ArticleId IdType="pmc">PMC8753023</ArticleId><ArticleId IdType="pubmed">35022007</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo C-L, Pilling LC, Atkins JL, Masoli JAH, Delgado J, Kuchel GA, et al. APOE e4 genotype predicts severe COVID-19 in the UK biobank community cohort. J. Gerontol. Ser. A. 2020;75:2231&#x2013;2232. doi: 10.1093/gerona/glaa131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glaa131</ArticleId><ArticleId IdType="pmc">PMC7314139</ArticleId><ArticleId IdType="pubmed">32451547</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H, Larsen CP, Hernandez-Arroyo CF, Mohamed MMB, Caza T, Sharshir M, et al. AKI and collapsing glomerulopathy associated with COVID-19 and APOL 1 high-risk genotype. JASN. 2020;31:1688&#x2013;1695. doi: 10.1681/ASN.2020050558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2020050558</ArticleId><ArticleId IdType="pmc">PMC7460910</ArticleId><ArticleId IdType="pubmed">32561682</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Host Genetics Initiative, COVID-19 host genetics initiativeleadership, Niemi MEK, Karjalainen J, Liao RG, Neale BM, et al. Mapping the human genetic architecture of COVID-19. Nature. 2021;600:472&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8674144</ArticleId><ArticleId IdType="pubmed">34237774</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Antonio M, Nguyen JP, Arthur TD, Matsui H, D&#x2019;Antonio-Chronowska A, Frazer KA, et al. SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues. Cell Rep.. 2021;37:110020. doi: 10.1016/j.celrep.2021.110020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.110020</ArticleId><ArticleId IdType="pmc">PMC8563343</ArticleId><ArticleId IdType="pubmed">34762851</ArticleId></ArticleIdList></Reference><Reference><Citation>Kousathanas A, Pairo-Castineira E, Rawlik K, Stuckey A, Odhams CA, Walker S, et al. Whole-genome sequencing reveals host factors underlying critical COVID-19. Nature. 2022;607:97&#x2013;103. doi: 10.1038/s41586-022-04576-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04576-6</ArticleId><ArticleId IdType="pmc">PMC9259496</ArticleId><ArticleId IdType="pubmed">35255492</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu X, Chong WP, Zhai Y, Zhang H, Zhang F, Wang S, et al. Functional polymorphisms of the CCL2 and MBL genes cumulatively increase susceptibility to severe acute respiratory syndrome coronavirus infection. J. Infect. 2015;71:101&#x2013;109. doi: 10.1016/j.jinf.2015.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2015.03.006</ArticleId><ArticleId IdType="pmc">PMC7112636</ArticleId><ArticleId IdType="pubmed">25818534</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmiedel BJ, Rocha J, Gonzalez-Colin C, Bhattacharyya S, Madrigal A, Ottensmeier CH, et al. COVID-19 genetic risk variants are associated with expression of multiple genes in diverse immune cell types. Nat. Commun. 2021;12:6760. doi: 10.1038/s41467-021-26888-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-26888-3</ArticleId><ArticleId IdType="pmc">PMC8604964</ArticleId><ArticleId IdType="pubmed">34799557</ArticleId></ArticleIdList></Reference><Reference><Citation>Baranova A, Cao H, Zhang F. Unraveling risk genes of COVID-19 by multi-omics integrative analyses. Front. Med. 2021;8:738687. doi: 10.3389/fmed.2021.738687.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.738687</ArticleId><ArticleId IdType="pmc">PMC8452849</ArticleId><ArticleId IdType="pubmed">34557504</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowman ER, Cameron CMA, Avery A, Gabriel J, Kettelhut A, Hecker M, et al. Levels of soluble CD14 and tumor necrosis factor receptors 1 and 2 may be predictive of death in severe Coronavirus Disease 2019. J. Infect. Dis.. 2021;223:805&#x2013;810. doi: 10.1093/infdis/jiaa744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa744</ArticleId><ArticleId IdType="pmc">PMC7799002</ArticleId><ArticleId IdType="pubmed">33249506</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu L, Zhu J, Liu D, Sun Y, Wu C. An integrative multiomics analysis identifies putative causal genes for COVID-19 severity. Genet. Med. 2021;23:2076&#x2013;2086. doi: 10.1038/s41436-021-01243-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41436-021-01243-5</ArticleId><ArticleId IdType="pmc">PMC8237048</ArticleId><ArticleId IdType="pubmed">34183789</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai Y, Wang J, Jeong H-H, Chen W, Jia P, Zhao Z. Association of CXCR6 with COVID-19 severity: Delineating the host genetic factors in transcriptomic regulation [Internet] Genetics. 2021 doi: 10.1101/2021.02.17.431554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.02.17.431554</ArticleId><ArticleId IdType="pmc">PMC8216591</ArticleId><ArticleId IdType="pubmed">34155559</ArticleId></ArticleIdList></Reference><Reference><Citation>Posadas-S&#xe1;nchez R, S&#xe1;nchez-Mu&#xf1;oz F, Guzm&#xe1;n-Mart&#xed;n CA, Hern&#xe1;ndez-D&#xed;az Couder A, Rojas-Velasco G, Fragoso JM, et al. Dipeptidylpeptidase-4 levels and DPP4 gene polymorphisms in patients with COVID-19. Association with disease and with severity. Life Sci.. 2021;276:119410. doi: 10.1016/j.lfs.2021.119410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2021.119410</ArticleId><ArticleId IdType="pmc">PMC7989663</ArticleId><ArticleId IdType="pubmed">33774023</ArticleId></ArticleIdList></Reference><Reference><Citation>The GenOMICC Investigators, The ISARIC4C Investigators, The COVID-19 Human Genetics Initiative, 23andMe Investigators, BRACOVID Investigators, Gen-COVID Investigators, et al. Genetic mechanisms of critical illness in COVID-19. Nature. 2021;591:92&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">33307546</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Mart&#xed;nez R, Albaiceta GM, Amado-Rodr&#xed;guez L, Cuesta-Llavona E, G&#xf3;mez J, Garc&#xed;a-Clemente M, et al. The FCGR2A rs1801274 polymorphism was associated with the risk of death among COVID-19 patients. Clin. Immunol. 2022;236:108954. doi: 10.1016/j.clim.2022.108954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2022.108954</ArticleId><ArticleId IdType="pmc">PMC8824710</ArticleId><ArticleId IdType="pubmed">35149195</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu P, Ding L, Li X, Liu S, Cheng F, He Q, et al. Trans-ethnic genome-wide association study of severe COVID-19. Commun. Biol. 2021;4:1034. doi: 10.1038/s42003-021-02549-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-02549-5</ArticleId><ArticleId IdType="pmc">PMC8408224</ArticleId><ArticleId IdType="pubmed">34465887</ArticleId></ArticleIdList></Reference><Reference><Citation>Coto E, Albaiceta GM, Amado-Rodr&#xed;guez L, Garc&#xed;a-Clemente M, Cuesta-Llavona E, V&#xe1;zquez-Coto D, et al. FURIN gene variants (rs6224/rs4702) as potential markers of death and cardiovascular traits in severe COVID-19. J. Med. Virol. 2022;94:3589&#x2013;3595. doi: 10.1002/jmv.27748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27748</ArticleId><ArticleId IdType="pmc">PMC9088626</ArticleId><ArticleId IdType="pubmed">35355278</ArticleId></ArticleIdList></Reference><Reference><Citation>Fricke-Galindo I, Falf&#xe1;n-Valencia R. Genetics insight for COVID-19 susceptibility and severity: A review. Front. Immunol. 2021;12:622176. doi: 10.3389/fimmu.2021.622176.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.622176</ArticleId><ArticleId IdType="pmc">PMC8047200</ArticleId><ArticleId IdType="pubmed">33868239</ArticleId></ArticleIdList></Reference><Reference><Citation>Padhi S, Sahu S, Pati A, Mohanty AK, Panda AK. Minor allele of intercellular adhesion molecule-1 polymorphism (rs5498 1462A&gt;G) is associated with SARS-CoV-2 infection and related mortality. J. Infect. Dis.. 2021;224:734&#x2013;735. doi: 10.1093/infdis/jiab279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab279</ArticleId><ArticleId IdType="pmc">PMC8244367</ArticleId><ArticleId IdType="pubmed">34023882</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan KYK, Ching JCY, Xu MS, Cheung ANY, Yip S-P, Yam LYC, et al. Association of ICAM3 genetic variant with severe acute respiratory syndrome. J. Infect. Dis. 2007;196:271&#x2013;280. doi: 10.1086/518892.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/518892</ArticleId><ArticleId IdType="pmc">PMC7202406</ArticleId><ArticleId IdType="pubmed">17570115</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xf6;nfelder K, Breuckmann K, Elsner C, Dittmer U, Fistera D, Herbstreit F, et al. The influence of IFITM3 polymorphisms on susceptibility to SARS-CoV-2 infection and severity of COVID-19. Cytokine. 2021;142:155492. doi: 10.1016/j.cyto.2021.155492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2021.155492</ArticleId><ArticleId IdType="pmc">PMC7936555</ArticleId><ArticleId IdType="pubmed">33711707</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020;370:eabd4570. doi: 10.1126/science.abd4570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4570</ArticleId><ArticleId IdType="pmc">PMC7857407</ArticleId><ArticleId IdType="pubmed">32972995</ArticleId></ArticleIdList></Reference><Reference><Citation>Vietzen H, Zoufaly A, Traugott M, Aberle J, Aberle SW, Puchhammer-St&#xf6;ckl E. Deletion of the NKG2C receptor encoding KLRC2 gene and HLA-E variants are risk factors for severe COVID-19. Genet. Med. 2021;23:963&#x2013;967. doi: 10.1038/s41436-020-01077-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41436-020-01077-7</ArticleId><ArticleId IdType="pmc">PMC7835668</ArticleId><ArticleId IdType="pubmed">33500568</ArticleId></ArticleIdList></Reference><Reference><Citation>The Severe Covid-19 GWAS Group. Genomewide association study of severe covid-19 with respiratory failure. N. Engl. J. Med. 2020;383:1522&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7315890</ArticleId><ArticleId IdType="pubmed">32558485</ArticleId></ArticleIdList></Reference><Reference><Citation>Andolfo I, Russo R, Lasorsa VA, Cantalupo S, Rosato BE, Bonfiglio F, et al. Common variants at 21q223 locus influence MX1 and TMPRSS2 gene expression and susceptibility to severe COVID-19. Science. 2021;24:102322.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7968217</ArticleId><ArticleId IdType="pubmed">33748697</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland B, Sun Q, Wang W, Miller-Fleming T, Cox N, Graff M, et al. Genetic examination of hematological parameters in SARS-CoV-2 infection and COVID-19. Genet. Genomic Med.; 2022. 10.1101/2022.02.28.22271562</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10507673</ArticleId><ArticleId IdType="pubmed">37558590</ArticleId></ArticleIdList></Reference><Reference><Citation>Thibord F, Chan MV, Chen M-H, Johnson AD. A year of COVID-19 GWAS results from the GRASP portal reveals potential genetic risk factors. Hum. Genet. Genom. Adv. 2022;3:100095. doi: 10.1016/j.xhgg.2022.100095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xhgg.2022.100095</ArticleId><ArticleId IdType="pmc">PMC8863308</ArticleId><ArticleId IdType="pubmed">35224516</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S, Baranova A, Cao H, Chen J, Zhang X, Zhang F. Genetic mechanisms of COVID-19 and its association with smoking and alcohol consumption. Brief. Bioinform.. 2021;22:284. doi: 10.1093/bib/bbab284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbab284</ArticleId><ArticleId IdType="pubmed">34308962</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Der Made CI, Simons A, Schuurs-Hoeijmakers J, Van Den Heuvel G, Mantere T, Kersten S, et al. Presence of genetic variants among young men with severe COVID-19. JAMA. 2020;324:663. doi: 10.1001/jama.2020.13719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.13719</ArticleId><ArticleId IdType="pmc">PMC7382021</ArticleId><ArticleId IdType="pubmed">32706371</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou Y, Zhao J, Martin W, Kallianpur A, Chung MK, Jehi L, et al. New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis. BMC Med. 2020;18:216. doi: 10.1186/s12916-020-01673-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-020-01673-z</ArticleId><ArticleId IdType="pmc">PMC7360473</ArticleId><ArticleId IdType="pubmed">32664879</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelton JF, Shastri AJ, Fletez-Brant K, The 23andMe COVID-19 Team, Auton A, Chubb A, et al. The UGT2A1/UGT2A2 locus is associated with COVID-19-related loss of smell or taste. Nat. Genet. 2022;54:121&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">35039640</ArticleId></ArticleIdList></Reference><Reference><Citation>Horowitz JE, Kosmicki JA, Damask A, Sharma D, Roberts GHL, Justice AE, et al. Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease. Nat. Genet. 2022;54:382&#x2013;392. doi: 10.1038/s41588-021-01006-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-01006-7</ArticleId><ArticleId IdType="pmc">PMC9005345</ArticleId><ArticleId IdType="pubmed">35241825</ArticleId></ArticleIdList></Reference><Reference><Citation>Downes DJ, Cross AR, Hua P, Roberts N, Schwessinger R, Cutler AJ, et al. Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus. Nat. Genet. 2021;53:1606&#x2013;1615. doi: 10.1038/s41588-021-00955-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00955-3</ArticleId><ArticleId IdType="pmc">PMC7611960</ArticleId><ArticleId IdType="pubmed">34737427</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakanishi T, Pigazzini S, Degenhardt F, Cordioli M, Butler-Laporte G, Maya-Miles D, et al. Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality. Genet. Genom. Med.; 2021. 10.1101/2021.03.07.21252875</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8631592</ArticleId><ArticleId IdType="pubmed">34597274</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi, H., Shen, Q., Zhao, H., Qi, G., Gao, L. Network-based analysis revealed significant interactions between risk genes of severe COVID-19 and host genes interacted with SARS-CoV-2 proteins. Brief. Bioinform. 2022;23:bbab372.</Citation><ArticleIdList><ArticleId IdType="pubmed">34535795</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruz R, Diz-de Almeida S, L&#xf3;pez De Heredia M, Quintela I, Ceballos FC, Pita G, et al. Novel genes and sex differences in COVID-19 severity. Hum. Mol. Genet.. 2022;31:3789&#x2013;806. doi: 10.1093/hmg/ddac132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddac132</ArticleId><ArticleId IdType="pmc">PMC9652109</ArticleId><ArticleId IdType="pubmed">35708486</ArticleId></ArticleIdList></Reference><Reference><Citation>The COVID-19 Host Genetics Initiative, Ganna A. Mapping the human genetic architecture of COVID-19 by worldwide meta-analysis. Genet. Genom. Med.; 2021. 10.1101/2021.03.10.21252820</Citation></Reference><Reference><Citation>Zhang L, Sarangi V, Liu D, Ho M-F, Grassi AR, Wei L, et al. ACE2 and TMPRSS2 SARS-CoV-2 infectivity genes: deep mutational scanning and characterization of missense variants. Hum. Mol. Genet.. 2022;31:4183&#x2013;4192. doi: 10.1093/hmg/ddac157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddac157</ArticleId><ArticleId IdType="pmc">PMC9759330</ArticleId><ArticleId IdType="pubmed">35861636</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Ke Y, Xia X, Wang Y, Cheng F, Liu X, et al. Genome-wide association study of COVID-19 severity among the Chinese population. Cell Discov. 2021;7:76. doi: 10.1038/s41421-021-00318-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-021-00318-6</ArticleId><ArticleId IdType="pmc">PMC8408196</ArticleId><ArticleId IdType="pubmed">34465742</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeberg H, P&#xe4;&#xe4;bo S. A genomic region associated with protection against severe COVID-19 is inherited from Neandertals. Proc. Natl. Acad. Sci. USA. 2021;118:e2026309118. doi: 10.1073/pnas.2026309118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2026309118</ArticleId><ArticleId IdType="pmc">PMC7936282</ArticleId><ArticleId IdType="pubmed">33593941</ArticleId></ArticleIdList></Reference><Reference><Citation>Babraham Bioinformatics - FastQC A Quality Control tool for High Throughput Sequence Data [Internet]. [cited 2023 Sep 3]. https://www.bioinformatics.babraham.ac.uk/projects/fastqc/</Citation></Reference><Reference><Citation>Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics. 2010;26:589&#x2013;595. doi: 10.1093/bioinformatics/btp698.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp698</ArticleId><ArticleId IdType="pmc">PMC2828108</ArticleId><ArticleId IdType="pubmed">20080505</ArticleId></ArticleIdList></Reference><Reference><Citation>Kendig KI, Baheti S, Bockol MA, Drucker TM, Hart SN, Heldenbrand JR, et al. Sentieon DNASeq variant calling workflow demonstrates strong computational performance and accuracy. Front. Genet. 2019;10:736. doi: 10.3389/fgene.2019.00736.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2019.00736</ArticleId><ArticleId IdType="pmc">PMC6710408</ArticleId><ArticleId IdType="pubmed">31481971</ArticleId></ArticleIdList></Reference><Reference><Citation>VarSeq | Golden Helix, Inc. [Internet]. [cited 2023 Sep 3]. https://www.goldenhelix.com/products/VarSeq/</Citation></Reference><Reference><Citation>Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The sequence alignment/map format and SAMtools. Bioinformatics. 2009;25:2078&#x2013;2079. doi: 10.1093/bioinformatics/btp352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp352</ArticleId><ArticleId IdType="pmc">PMC2723002</ArticleId><ArticleId IdType="pubmed">19505943</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK, Baheti S, et al. REVEL: An ensemble method for predicting the pathogenicity of rare missense variants. Am. J. Hum. Genet. 2016;99:877&#x2013;885. doi: 10.1016/j.ajhg.2016.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2016.08.016</ArticleId><ArticleId IdType="pmc">PMC5065685</ArticleId><ArticleId IdType="pubmed">27666373</ArticleId></ArticleIdList></Reference><Reference><Citation>Sol&#xe9; X, Guin&#xf3; E, Valls J, Iniesta R, Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics. 2006;22:1928&#x2013;1929. doi: 10.1093/bioinformatics/btl268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btl268</ArticleId><ArticleId IdType="pubmed">16720584</ArticleId></ArticleIdList></Reference><Reference><Citation>Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, et al. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007;81:559&#x2013;575. doi: 10.1086/519795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/519795</ArticleId><ArticleId IdType="pmc">PMC1950838</ArticleId><ArticleId IdType="pubmed">17701901</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263&#x2013;265. doi: 10.1093/bioinformatics/bth457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bth457</ArticleId><ArticleId IdType="pubmed">15297300</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhury MZI, Turin TC. Variable selection strategies and its importance in clinical prediction modelling. Fam. Med. Com. Health. 2020;8:e000262. doi: 10.1136/fmch-2019-000262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/fmch-2019-000262</ArticleId><ArticleId IdType="pmc">PMC7032893</ArticleId><ArticleId IdType="pubmed">32148735</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin FJ, Amode MR, Aneja A, Austine-Orimoloye O, Azov AG, Barnes I, et al. Ensembl 2023. Nucleic Acids Res.. 2023;51:D933&#x2013;D941. doi: 10.1093/nar/gkac958.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkac958</ArticleId><ArticleId IdType="pmc">PMC9825606</ArticleId><ArticleId IdType="pubmed">36318249</ArticleId></ArticleIdList></Reference><Reference><Citation>Lafferty EI, Flaczyk A, Angers I, Homer R, d&#x2019;Hennezel E, Malo D, et al. An ENU-induced splicing mutation reveals a role for Unc93b1 in early immune cell activation following influenza A H1N1 infection. Genes Immun. 2014;15:320&#x2013;332. doi: 10.1038/gene.2014.22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gene.2014.22</ArticleId><ArticleId IdType="pmc">PMC4978536</ArticleId><ArticleId IdType="pubmed">24848930</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical &amp; mortal COVID-19 cases: A systematic literature review and meta-analysis. J. Infect. 2020;81:e16&#x2013;25. doi: 10.1016/j.jinf.2020.04.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.04.021</ArticleId><ArticleId IdType="pmc">PMC7177098</ArticleId><ArticleId IdType="pubmed">32335169</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D, Zhang T, Wang Y, Xia L. The centrality of obesity in the Course of Severe COVID-19. Front. Endocrinol. 2021;12:620566. doi: 10.3389/fendo.2021.620566.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2021.620566</ArticleId><ArticleId IdType="pmc">PMC7992974</ArticleId><ArticleId IdType="pubmed">33776917</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim S, Bae JH, Kwon H-S, Nauck MA. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat. Rev. Endocrinol. 2021;17:11&#x2013;30. doi: 10.1038/s41574-020-00435-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-020-00435-4</ArticleId><ArticleId IdType="pmc">PMC7664589</ArticleId><ArticleId IdType="pubmed">33188364</ArticleId></ArticleIdList></Reference><Reference><Citation>He X, Cheng X, Feng X, Wan H, Chen S, Xiong M. Clinical symptom differences between mild and severe COVID-19 patients in China: A meta-analysis. Front Public Health. 2021;8:561264. doi: 10.3389/fpubh.2020.561264.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.561264</ArticleId><ArticleId IdType="pmc">PMC7841395</ArticleId><ArticleId IdType="pubmed">33520906</ArticleId></ArticleIdList></Reference><Reference><Citation>Parasher A. COVID-19: Current understanding of its Pathophysiology, Clinical presentation and treatment. Postgrad. Med. J. 2021;97:312&#x2013;320. doi: 10.1136/postgradmedj-2020-138577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/postgradmedj-2020-138577</ArticleId><ArticleId IdType="pmc">PMC10017004</ArticleId><ArticleId IdType="pubmed">32978337</ArticleId></ArticleIdList></Reference><Reference><Citation>Foster KJ, Jauregui E, Tajudeen B, Bishehsari F, Mahdavinia M. Smell loss is a prognostic factor for lower severity of coronavirus disease 2019. Ann. Allergy Asthma Immunol. 2020;125:481&#x2013;483. doi: 10.1016/j.anai.2020.07.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anai.2020.07.023</ArticleId><ArticleId IdType="pmc">PMC7380219</ArticleId><ArticleId IdType="pubmed">32717301</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, Palese A, Venturini M, De Martino M, Gerussi V, Graziano E, et al. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin. Microbiol. Infect. 2021;27:1507&#x2013;1513. doi: 10.1016/j.cmi.2021.05.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.05.033</ArticleId><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook, H., Raza, S., Nowell, J., Young, M., Edison, P. Long covid&#x2014;mechanisms, risk factors, and management. BMJ. 2021;n1648.</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira JF, de&#xc1;vila RE, deOliveira NR, daCunhaSeverinoSampaio N, Botelho M, Gon&#xe7;alves FA, et al. Persistent symptoms, quality of life, and risk factors in long COVID: A cross-sectional study of hospitalized patients in Brazil. Int. J. Infect. Dis. 2022;122:1044&#x2013;51. doi: 10.1016/j.ijid.2022.07.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.07.063</ArticleId><ArticleId IdType="pmc">PMC9330427</ArticleId><ArticleId IdType="pubmed">35908724</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya AA, Akbari A, Emami A, Lotfi M, Rostamihosseinkhani M, Nemati H, et al. Risk factors associated with long COVID syndrome: A retrospective study. Iran. J. Med. Sci.. 2021. 10.30476/ijms.2021.92080.2326</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8611223</ArticleId><ArticleId IdType="pubmed">34840383</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams FMK, Freidin MB, Mangino M, Couvreur S, Visconti A, Bowyer RCE, et al. Self-reported symptoms of COVID-19, including symptoms most predictive of SARS-CoV-2 infection Are Heritable. Twin. Res. Hum. Genet. 2020;23:316&#x2013;321. doi: 10.1017/thg.2020.85.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/thg.2020.85</ArticleId><ArticleId IdType="pubmed">33558003</ArticleId></ArticleIdList></Reference><Reference><Citation>Degenhardt F, Ellinghaus D, Juzenas S, Lerga-Jaso J, Wendorff M, Maya-Miles D, et al. Detailed stratified GWAS analysis for severe COVID-19 in four European populations. Hum. Mol. Genet. 2022;31:3945&#x2013;3966. doi: 10.1093/hmg/ddac158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddac158</ArticleId><ArticleId IdType="pmc">PMC9703941</ArticleId><ArticleId IdType="pubmed">35848942</ArticleId></ArticleIdList></Reference><Reference><Citation>Fingerlin TE, Murphy E, Zhang W, Peljto AL, Brown KK, Steele MP, et al. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat. Genet. 2013;45:613&#x2013;620. doi: 10.1038/ng.2609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2609</ArticleId><ArticleId IdType="pmc">PMC3677861</ArticleId><ArticleId IdType="pubmed">23583980</ArticleId></ArticleIdList></Reference><Reference><Citation>Witoelar A, Jansen IE, Wang Y, Desikan RS, Gibbs JR, Blauwendraat C, et al. Genome-wide pleiotropy between parkinson disease and autoimmune diseases. JAMA Neurol. 2017;74:780. doi: 10.1001/jamaneurol.2017.0469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.0469</ArticleId><ArticleId IdType="pmc">PMC5710535</ArticleId><ArticleId IdType="pubmed">28586827</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang S, Shu X. Effect of CCR3 gene on related inflammatory cells in respiratory allergic diseases. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021;35:80&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10128548</ArticleId><ArticleId IdType="pubmed">33540982</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai M, Zhu X, Yu J, Yuan J, Zhu Y, Bao Y, et al. CCR3 gene knockout in bone marrow cells ameliorates combined allergic rhinitis and asthma syndrome (CARAS) by reducing airway inflammatory cell infiltration and Th2 cytokines expression in mice model. Int. Immunopharmacol. 2022;104:108509. doi: 10.1016/j.intimp.2021.108509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.108509</ArticleId><ArticleId IdType="pubmed">34998035</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil BA, Noha Mousaad E, Maghazachi AA. Chemokines and chemokine receptors during COVID-19 infection. Comput. Struct. Biotechnol. J. 2021;19:976&#x2013;88. doi: 10.1016/j.csbj.2021.01.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.csbj.2021.01.034</ArticleId><ArticleId IdType="pmc">PMC7859556</ArticleId><ArticleId IdType="pubmed">33558827</ArticleId></ArticleIdList></Reference><Reference><Citation>Stikker BS, Stik G, van Ouwerkerk AF, Trap L, Spicuglia S, Hendriks RW, et al. Severe COVID-19-associated variants linked to chemokine receptor gene control in monocytes and macrophages. Genome Biol. 2022;23:96. doi: 10.1186/s13059-022-02669-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-022-02669-z</ArticleId><ArticleId IdType="pmc">PMC9009160</ArticleId><ArticleId IdType="pubmed">35421995</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V, Flanders SA, O&#x2019;Malley M, Malani AN, Prescott HC. Sixty-day outcomes among patients hospitalized with COVID-19. Ann. Intern. Med. 2021;174:576&#x2013;578. doi: 10.7326/M20-5661.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5661</ArticleId><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagata K, Nishiyama C. IL-10 in mast cell-mediated immune responses: Anti-inflammatory and proinflammatory roles. IJMS. 2021;22:4972. doi: 10.3390/ijms22094972.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22094972</ArticleId><ArticleId IdType="pmc">PMC8124430</ArticleId><ArticleId IdType="pubmed">34067047</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin LB, Weinstock LB, Molderings GJ. Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome. Int. J. Infect. Dis. 2020;100:327&#x2013;332. doi: 10.1016/j.ijid.2020.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7529115</ArticleId><ArticleId IdType="pubmed">32920235</ArticleId></ArticleIdList></Reference><Reference><Citation>Batiha GE-S, Al-kuraishy HM, Al-Gareeb AI, Welson NN. Pathophysiology of post-COVID syndromes: a new perspective. Virol J. 2022;19:158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9548310</ArticleId><ArticleId IdType="pubmed">36210445</ArticleId></ArticleIdList></Reference><Reference><Citation>Zguro K, Fallerini C, Fava F, Furini S, Renieri A. Host genetic basis of COVID-19: from methodologies to genes. Eur. J. Hum. Genet. 2022;30:899&#x2013;907. doi: 10.1038/s41431-022-01121-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41431-022-01121-x</ArticleId><ArticleId IdType="pmc">PMC9135575</ArticleId><ArticleId IdType="pubmed">35618891</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitrovi&#x10d; M, Patsopoulos NA, Beecham AH, Dankowski T, Goris A, Dubois B, et al. Low-frequency and rare-coding variation contributes to multiple sclerosis risk. Cell. 2018;175:1679&#x2013;1687.e7. doi: 10.1016/j.cell.2018.09.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.09.049</ArticleId><ArticleId IdType="pmc">PMC6269166</ArticleId><ArticleId IdType="pubmed">30343897</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhangadamajhi G, Rout R. Association of TLR3 functional variant (rs3775291) with COVID-19 susceptibility and death: a population-scale study. Hum. Cell. 2021;34:1025&#x2013;1027. doi: 10.1007/s13577-021-00510-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13577-021-00510-6</ArticleId><ArticleId IdType="pmc">PMC7897730</ArticleId><ArticleId IdType="pubmed">33616867</ArticleId></ArticleIdList></Reference><Reference><Citation>Neiers, F., Jarriault, D., Menetrier, F., Briand, L., Heydel, J.-M. The odorant metabolizing enzyme UGT2A1: Immunolocalization and impact of the modulation of its activity on the olfactory response. He P, editor. PLoS ONE. 2021;16:e0249029.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7993815</ArticleId><ArticleId IdType="pubmed">33765098</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvey WT, Carabelli AM, Jackson B, Gupta RK, Thomson EC, Harrison EM, et al. SARS-CoV-2 variants, spike mutations and immune escape. Nat. Rev. Microbiol. 2021;19:409&#x2013;424. doi: 10.1038/s41579-021-00573-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-021-00573-0</ArticleId><ArticleId IdType="pmc">PMC8167834</ArticleId><ArticleId IdType="pubmed">34075212</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao K, Tzou PL, Nouhin J, Gupta RK, De Oliveira T, Kosakovsky Pond SL, et al. The biological and clinical significance of emerging SARS-CoV-2 variants. Nat. Rev. Genet. 2021;22:757&#x2013;773. doi: 10.1038/s41576-021-00408-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41576-021-00408-x</ArticleId><ArticleId IdType="pmc">PMC8447121</ArticleId><ArticleId IdType="pubmed">34535792</ArticleId></ArticleIdList></Reference><Reference><Citation>Molina-Mora JA, Reales-Gonz&#xe1;lez J, Camacho E, Duarte-Mart&#xed;nez F, Tsukayama P, Soto-Garita C, et al. Overview of the SARS-CoV-2 genotypes circulating in Latin America during 2021. Front. Public Health. 2023;11:1095202. doi: 10.3389/fpubh.2023.1095202.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1095202</ArticleId><ArticleId IdType="pmc">PMC10018007</ArticleId><ArticleId IdType="pubmed">36935725</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, Azman AS, Chen X, Zou J, Tian Y, Sun R, et al. Global landscape of SARS-CoV-2 genomic surveillance and data sharing. Nat. Genet. 2022;54:499&#x2013;507. doi: 10.1038/s41588-022-01033-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-022-01033-y</ArticleId><ArticleId IdType="pmc">PMC9005350</ArticleId><ArticleId IdType="pubmed">35347305</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SL, Flanagan KL. Sex differences in immune responses. Nat. Rev. Immunol. 2016;16:626&#x2013;638. doi: 10.1038/nri.2016.90.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2016.90</ArticleId><ArticleId IdType="pubmed">27546235</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh B, Hwangbo S, Jung T, Min K, Lee C, Apio C, et al. Prediction models for the clinical severity of patients with COVID-19 in Korea: Retrospective multicenter cohort study. J. Med. Internet. Res. 2021;23:e25852. doi: 10.2196/25852.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/25852</ArticleId><ArticleId IdType="pmc">PMC8054775</ArticleId><ArticleId IdType="pubmed">33822738</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2. Am. J. Respir. Crit. Care Med. 2020;202:756&#x2013;759. doi: 10.1164/rccm.202001-0179LE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202001-0179LE</ArticleId><ArticleId IdType="pmc">PMC7462411</ArticleId><ArticleId IdType="pubmed">32663409</ArticleId></ArticleIdList></Reference><Reference><Citation>Dite GS, Murphy NM, Allman R. An integrated clinical and genetic model for predicting risk of severe COVID-19: A population-based case&#x2013;control study. Novelli G, editor. PLoS ONE. 2021;16:e0247205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7886160</ArticleId><ArticleId IdType="pubmed">33592063</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>